Curio wins FDA approval for its postpartum depression digital therapeutic
Curio’s MamaLift Plus is an eight-week prescription digital therapeutic that provides symptomatic relief for postpartum depression.
24 April 2024
24 April 2024
Curio’s MamaLift Plus is an eight-week prescription digital therapeutic that provides symptomatic relief for postpartum depression.
The two technologies are designed to facilitate the detection and analysis of potential seizure in patients.
BowTie is the only sacroiliac (SI) fusion device featuring both intra-articular and transfixing components.
The Zenition 30 mobile C-arm offers enhanced flexibility, control, and personalisation for surgeons.
Results from the trial indicate that Injectrode can effectively deliver electrical neuromodulation at therapeutic levels.
The two clinical trials are conducted in US and Europe to evaluate safety and performance of the HYALEX Knee Cartilage System.
This next-generation computer-assisted vacuum thrombectomy system can remove venous thrombus and in treating pulmonary emboli.
As consumer tech is better able to monitor basic elements of health, patients are being asked to bring their own device to a clinical trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.